Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 3084-3090

  Losa, Marco ^a   Giovanelli, Massimo ^a   Persani, Luca ^a   Mortini, Pietro ^a   Faglia, Giovanni ^a   Beck Peccoz, Paolo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING GLOBULIN; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; EUTHYROIDISM; FEMALE; FOLLOW UP; HORMONAL REGULATION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; THYROID FUNCTION; THYROID SURGERY; THYROTROPIN RELEASE;

ADENOMA; ADULT; ENDOCRINE GLANDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; POSTOPERATIVE PERIOD; REMISSION INDUCTION; THYROID HORMONES; THYROTROPIN;

EID: 0029787256     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.3084     Document Type: Article

References (32)

1. Nicoloff JT, Spencer CA. 1990 The use and misuse of the sensitive thyrotropin assay. J Clin Endocrinol Metab. 71:553 - 558.
2. Smallridge RC. 1993 Thyrotropin-secreting tumors. In: Mazzaferri EL, Samaan NA, eds. Endocrine tumors. Boston: Blackwell; 136 - 151.
3. Beck-Peccoz P, Persani L. 1996 Thyrotropin (TSH)-secreting pituitary tumors: endocrinology, clinical aspects and treatment. In: Landolt AM, Vance ML, Reilly PL, eds. Pituitary adenomas: biology, diagnosis and treatment. London: Churchill Livingstone; 139 - 155.
4. Saeger W, Lüdecke DK. 1982 Pituitary adenomas with hyperfunction of TSH. Frequency, histological classification, immunocytochemistry and ultrastructure. Virchows Arch [Pathol Anat] 394:255 - 267.
5. Wilson CB. 1984 A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg. 61.814 - 833.
6. Mindermann T, Wilson CB. 1993 Thyrotropin-producing pituitary adenomas. J Neurosurg. 79:521 - 5527.
7. Weintraub BD, Gershengorn MC, Kourides IA, Fein H. 1981 Inappropriate secretion of thyroid-stimulating hormone. Ann Intern Med. 95:339 - 351.
8. Faglia G, Beck-Peccoz P, Piscitelli G, Medri G. 1987 Inappropriate secretion of thyrotropin by the pituitary. Horm Res. 26:79 - 99.
9. Hill SA, Falko JM, Wilson CB, Hunt WE. 1982 Thyrotrophin-producing pituitary adenomas. J Neurosurg. 57:515 - 519.
10. Grisoli F, Leclercq T, Winteler JP, et al. 1986 Thyroid-stimulating pituitary adenomas and hyperthyroidism. Surg Neurol. 25.361 - 368.
11. McCutcheon IE, Weintraub BD, Oldfield EH. 1990 Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg. 73:674 - 683.
12. Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A. 1991 Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab. 2:477 - 483.
13. Beck-Peccoz P, Piscitelli G, Amr S, et al. 1986 Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and α-subunit: evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab. 62:704 - 711.
14. Beck-Peccoz P, Mariotti S, Guillausseau J, et al. 1989 Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201 - 995. J Clin Endocrinol Metab. 68:208 - 214.
15. Beck-Peccoz P, Roncoroni R, Mariotti S, et al. 1990 Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in non-neoplastic IST. J Clin Endocrinol Metab. 71:19 - 25.
16. Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. 1977 Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identity patients with pituitary tumors. J Clin Endocrinol Metab. 45:534 - 543.
17. Beck-Peccoz P, Persani L, Faglia G. 1992 Glycoprotein hormone α-subunit in pituitary adenomas. Trends Endocrinol Metab. 3:41 - 45.
18. Antonelli AR, Cappiello J, Bigoni AG, et al. 1995 Widened transnasal surgical approach for removal of huge, forward-spreading pituitary neoplasms. In: Mazzoni A, Sanna M, eds. Skull base surgery. Update I. Amsterdam: Kugler; 229 - 235.
19. Terzolo M, Orlandi F, Bassetti M, et al. 1991 Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alphasubunit alone and another cosecreting alpha-subunit and thyrotropin. J Clin Endocrinol Metab. 72:415 - 421.
20. Kuzuya N, Inoue K, Ishibashi M, et al. 1990 Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas, responses of TSH, alpha-subunit and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells, J Clin Endocrinol Metab. 71:1103 - 1111.
21. Felix I, Asa SL, Kovacs K, Horvath E, Smyth HS. 1994 Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Arch Pathol Lab Med. 118:66 - 70.
22. Landolt AM, Froesch ER, König MP. 1988 Spontaneous postoperative normalization of growth hormone levels in two patients with acromegaly not cured by transsphenoidal surgery. Neurosurgery. 23:634 - 637.
23. Davis DH, Laws Jr ER, Ilstrup DM, et al. 1993 Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg. 79:70 - 75.
24. Refetoff S, Weiss RE, Usala SJ. 1993 The syndromes of resistance to thyroid hormone. Endocr Rev. 14:348 - 399.
25. Bevan JS, Burke CW, Esiri MM, et al. 1989 Studies of two thyrotrophinsecreting pituitary adenomas: evidence for dopamine receptor deficiency. Clin Endocrinol (Oxf). 31:59 - 70.
26. Gesundheit N, Petrick PA, Nissim M, et al. 1989 Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med. 111:827 - 835.
27. Losa M, Oeckler R, Schopohl J, Müller OA, Alba-Lopez J, von Werder K. 1989 Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. J Neurosurg. 70:561 - 567.
28. Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE, Selman W. 1987 Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. J Lab Clin Med. 109:346 - 354.
29. Serri O, Rasio E, Beauregard H, Hardy J, Somma M. 1983 Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med. 309:280 - 285.
30. Tahir AH, Sheeler LR. 1992 Recurrent Cushing's disease after transsphenoidal surgery. Arch Intern Med. 152:977 - 981.
31. Mariotti S, Anelli S, Bartalena L, et al. 1987 Familial hyperthyroidism due to nonneoplastic inappropriate TSH secretion associated with sellar abnormalities. J Endocrinol Invest. 10(Suppl 1):20.
32. Chanson P, Weintraub BD, Harris AG. 1993 Octreotide therapy for thyroid stimulating secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med. 119:236 - 240.